|
FY2025
12 months to Dec 31, 2025
|
FY2024
12 months to Dec 31, 2024
|
FY2023
12 months to Dec 31, 2023
|
|
|---|---|---|---|
| Revenues | |||
| Gross premiums written | |||
| Reinsurance premiums ceded | |||
| Net premiums written | |||
| Net change in unearned premiums | |||
| Net premiums earned | |||
| Net realized and unrealized gains (losses) on investments | |||
| Net investment income (loss) | |||
| Total net realized and unrealized gains (losses) on investments and net investment income (loss) | |||
| Net gain on sale of equity method investment | |||
| Other income (loss) | |||
| Net foreign exchange gains (losses) | |||
| Total revenues | |||
| Expenses | |||
| Losses and loss adjustment expenses | |||
| Acquisition costs | |||
| General and administrative expenses | |||
| Impairment of goodwill | |||
| Amortization of intangible assets | |||
| Interest expense | |||
| Total expenses | |||
| Income (loss) before income tax | |||
| Income tax expense (benefit) | |||
| Net income (loss) | |||
| Net income (loss) attributable to non-controlling interest | |||
| Net income (loss) and other comprehensive income (loss) attributable to common shareholders | |||
| Per share data | |||
| Basic income (loss) per share attributable to common shareholders | |||
| Diluted income (loss) per share attributable to common shareholders |
Loading...